metadata:
  source: MASLDOrganoCrosstalk
  generated at: 2026-05-08T13:46:00
  compatible with: Yggdrasil knowledge graph (mock JSON-LD)
  disclaimer: ⚠️ 디스클레이머: 이 출력은 mock 합성 데이터 기반 연구 아이디어 보조용입니다. 임상 진료에 직접 사용하지 마십시오. 실제 활용 시 PubMed/Europe PMC 원천 재검증 필수.

organ/liver
type: Organ
label: 간

organ/gut
type: Organ
label: 장

organ/adipose visceral
type: Organ
label: 내장지방

organ/adipose subcutaneous
type: Organ
label: 피하지방

organ/BAT
type: Organ
label: 갈색지방

organ/skeletal muscle
type: Organ
label: 골격근

organ/bone
type: Organ
label: 뼈

organ/brain
type: Organ
label: 뇌

organ/kidney
type: Organ
label: 신장

organ/heart
type: Organ
label: 심장

organ/thyroid
type: Organ
label: 갑상선

organ/gonad
type: Organ
label: 생식선

organ/pancreas
type: Organ
label: 췌장

organ/immune system
type: Organ
label: 면역계

organ/skin
type: Organ
label: 피부

mediator/FGF21
type: Mediator
label: FGF21

mediator/FGF19
type: Mediator
label: FGF19

mediator/GDF15
type: Mediator
label: GDF15

mediator/adiponectin
type: Mediator
label: 아디포넥틴

mediator/leptin
type: Mediator
label: 렙틴

mediator/resistin
type: Mediator
label: 레지스틴

mediator/TNF alpha
type: Mediator
label: TNF알파

mediator/IL6
type: Mediator
label: IL-6

mediator/IL17A
type: Mediator
label: IL-17A

mediator/IL18
type: Mediator
label: IL-18

mediator/MCP1
type: Mediator
label: MCP-1

mediator/CXCL10
type: Mediator
label: CXCL10

mediator/irisin
type: Mediator
label: 이리신

mediator/myostatin
type: Mediator
label: 마이오스타틴

mediator/BAIBA
type: Mediator
label: BAIBA

mediator/osteocalcin
type: Mediator
label: 오스테오칼신

mediator/sclerostin
type: Mediator
label: 스클레로스틴

mediator/lipocalin2
type: Mediator
label: 리포칼린-2

mediator/fetuinA
type: Mediator
label: 페투인-A

mediator/selenoprotein P
type: Mediator
label: 셀레노프로틴-P

mediator/ANGPTL4
type: Mediator
label: ANGPTL4

mediator/ANGPTL8
type: Mediator
label: ANGPTL8 (베타트로핀)

mediator/GLP1
type: Mediator
label: GLP-1

mediator/GIP
type: Mediator
label: GIP

mediator/PYY
type: Mediator
label: PYY

mediator/ghrelin
type: Mediator
label: 그렐린

mediator/bile acid TCA
type: Mediator
label: 타우로콜산

mediator/TMAO
type: Mediator
label: TMAO

mediator/indole3acetate
type: Mediator
label: 인돌-3-아세테이트

mediator/LPS
type: Mediator
label: LPS(내독소)

mediator/SCFA butyrate
type: Mediator
label: 부티르산(SCFA)

mediator/ceramide C16
type: Mediator
label: C16-세라마이드

mediator/DAG
type: Mediator
label: DAG

mediator/lysoPC
type: Mediator
label: lysoPC

mediator/miR122
type: Mediator
label: miR-122

mediator/miR34a
type: Mediator
label: miR-34a

mediator/miR103
type: Mediator
label: miR-103

mediator/exosome AdipoExos
type: Mediator
label: 지방세포유래 엑소좀

mediator/exosome HepExos
type: Mediator
label: 간세포유래 엑소좀

mediator/BMP4
type: Mediator
label: BMP4

mediator/BMP7
type: Mediator
label: BMP7

mediator/T3
type: Mediator
label: T3

mediator/rT3
type: Mediator
label: rT3(역T3)

mediator/estradiol
type: Mediator
label: 에스트라디올

mediator/testosterone
type: Mediator
label: 테스토스테론

mediator/SHBG
type: Mediator
label: SHBG

mediator/cortisol
type: Mediator
label: 코르티솔

mediator/insulin
type: Mediator
label: 인슐린

mediator/glucagon
type: Mediator
label: 글루카곤

mediator/amylin
type: Mediator
label: 아밀린

mediator/BCAA leucine
type: Mediator
label: 분지쇄아미노산(루신)

mediator/kynurenine
type: Mediator
label: 키누레닌

mediator/lactate
type: Mediator
label: 락테이트

mediator/BHB
type: Mediator
label: 베타하이드록시부티르산

mediator/uric acid
type: Mediator
label: 요산

mediator/homoarginine
type: Mediator
label: 호모아르기닌

mediator/FGF23
type: Mediator
label: FGF23

mediator/klotho
type: Mediator
label: Klotho

mediator/ANP
type: Mediator
label: ANP

mediator/BNP
type: Mediator
label: BNP

mediator/neuregulin4
type: Mediator
label: Neuregulin-4

outcome/MASLD steatosis
type: Outcome
label: MASLD 지방증

outcome/MASH NAS
type: Outcome
label: MASH NAS≥4

outcome/fibrosis F2
type: Outcome
label: 유의한 섬유화(F2)

outcome/fibrosis F3
type: Outcome
label: 진행성 섬유화(F3)

outcome/cirrhosis F4
type: Outcome
label: 간경변(F4)

outcome/HCC
type: Outcome
label: 간세포암

outcome/MAFLD resolution
type: Outcome
label: MASH 해소

outcome/fibrosis regression 1stage
type: Outcome
label: 섬유화 1단계 호전

outcome/ALT normalization
type: Outcome
label: ALT 정상화

outcome/MRI PDFF 30reduction
type: Outcome
label: MRI-PDFF 30%↓

outcome/MRE stiffness
type: Outcome
label: MRE 강도

outcome/FIB4
type: Outcome
label: FIB-4

outcome/ELF
type: Outcome
label: ELF score

outcome/Pro C3
type: Outcome
label: Pro-C3

outcome/T2DM incident
type: Outcome
label: 신규 2형 당뇨병

outcome/MetS resolution
type: Outcome
label: 대사증후군 해소

outcome/weight 5pct loss
type: Outcome
label: 체중 5%↓

outcome/weight 10pct loss
type: Outcome
label: 체중 10%↓

outcome/HbA1c reduction
type: Outcome
label: HbA1c 감소

outcome/MACE 3point
type: Outcome
label: 3-point MACE

outcome/HFpEF admission
type: Outcome
label: HFpEF 입원

outcome/AF incident
type: Outcome
label: 신규 심방세동

outcome/stroke ischemic
type: Outcome
label: 허혈성 뇌졸중

outcome/CKD eGFR decline
type: Outcome
label: eGFR 감소(CKD)

outcome/DKD progression
type: Outcome
label: DKD 진행

outcome/albuminuria progression
type: Outcome
label: 단백뇨 진행

outcome/sarcopenia AWGS
type: Outcome
label: 근감소증(AWGS)

outcome/osteoporotic fx
type: Outcome
label: 골다공증성 골절

outcome/cognitive decline
type: Outcome
label: 인지기능 저하

outcome/depression PHQ9
type: Outcome
label: 우울(PHQ-9)

outcome/OSA AHI
type: Outcome
label: OSA(AHI)

outcome/PCOS phenotype
type: Outcome
label: PCOS 표현형

outcome/hypogonadism male
type: Outcome
label: 남성 성선기능저하

outcome/subclinical hypothyroid
type: Outcome
label: 준임상 갑상선저하

outcome/psoriasis PASI
type: Outcome
label: 건선(PASI)

outcome/QoL CLDQNAFLD
type: Outcome
label: 삶의 질(CLDQ-NAFLD)

outcome/all cause mortality
type: Outcome
label: 전원인 사망

outcome/liver related mortality
type: Outcome
label: 간관련 사망

outcome/cardiovascular mortality
type: Outcome
label: 심혈관 사망

outcome/extrahepatic cancer
type: Outcome
label: 간외 암(CRC/breast 등)

drug/resmetirom
type: Drug
label: 레스메티롬

drug/pegozafermin
type: Drug
label: 페고자페르민

drug/efruxifermin
type: Drug
label: 에프룩시페르민

drug/survodutide
type: Drug
label: 수르보두타이드

drug/MariTide
type: Drug
label: 마리타이드

drug/CagriSema
type: Drug
label: 카그리세마

drug/tirzepatide
type: Drug
label: 티르제파타이드

drug/semaglutide
type: Drug
label: 세마글루타이드

drug/obeticholic acid
type: Drug
label: 오베티콜릭산

drug/aldafermin
type: Drug
label: 알다페르민

drug/lanifibranor
type: Drug
label: 라니피브라노르

drug/denifanstat
type: Drug
label: 데니판스타트

drug/SMK 3962
type: Drug
label: SMK-3962

drug/tropifexor
type: Drug
label: 트로피페소르

drug/HPP737
type: Drug
label: HPP-737

drug/VK2809
type: Drug
label: VK2809

tuple/BAT adipose subcutaneous klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous leptin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous irisin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous fetuinA fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous BNP fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous FGF19 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous osteocalcin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous lipocalin2 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous GLP1 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous FGF21 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose subcutaneous adiponectin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_subcutaneous
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral leptin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral irisin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral fetuinA fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral BNP fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral FGF19 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral osteocalcin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral lipocalin2 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral GLP1 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral FGF21 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT adipose visceral adiponectin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/adipose_visceral
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone leptin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone irisin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone fetuinA fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone BNP fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone FGF19 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone osteocalcin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone lipocalin2 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone GLP1 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone FGF21 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT bone adiponectin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/bone
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain leptin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain irisin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain fetuinA fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain BNP fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain FGF19 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain osteocalcin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain lipocalin2 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain GLP1 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain FGF21 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT brain adiponectin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/brain
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad leptin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad irisin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad fetuinA fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad BNP fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad FGF19 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad osteocalcin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad lipocalin2 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad GLP1 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad FGF21 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gonad adiponectin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gonad
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut leptin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut irisin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut fetuinA fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut BNP fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut FGF19 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut osteocalcin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut lipocalin2 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut GLP1 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut FGF21 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT gut adiponectin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/gut
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart leptin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart irisin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart fetuinA fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart BNP fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart FGF19 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart osteocalcin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart lipocalin2 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart GLP1 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart FGF21 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT heart adiponectin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/heart
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system leptin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system irisin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system fetuinA fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system BNP fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system FGF19 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system osteocalcin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system lipocalin2 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system GLP1 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system FGF21 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT immune system adiponectin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/immune_system
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney leptin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney irisin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney fetuinA fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney BNP fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney FGF19 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney osteocalcin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney lipocalin2 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney GLP1 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney FGF21 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT kidney adiponectin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/kidney
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver klotho HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver klotho stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver klotho DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver klotho MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF23 HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF23 stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF23 DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF23 MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver SHBG HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver SHBG stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver SHBG DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver SHBG MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver GDF15 HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver GDF15 stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver GDF15 DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver GDF15 MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver leptin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver leptin HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver leptin stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver leptin DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver leptin MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/leptin
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver irisin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver irisin HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver irisin stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver irisin DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver irisin MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/irisin
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver fetuinA fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver fetuinA HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver fetuinA stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver fetuinA DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver fetuinA MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/fetuinA
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver BNP fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver BNP HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver BNP stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver BNP DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver BNP MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/BNP
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF19 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF19 HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF19 stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF19 DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF19 MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF19
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver osteocalcin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver osteocalcin HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver osteocalcin stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver osteocalcin DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver osteocalcin MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/osteocalcin
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver lipocalin2 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver lipocalin2 HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver lipocalin2 stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver lipocalin2 DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver lipocalin2 MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/lipocalin2
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver GLP1 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver GLP1 HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver GLP1 stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver GLP1 DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver GLP1 MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/GLP1
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF21 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF21 HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF21 stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF21 DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver FGF21 MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/FGF21
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver adiponectin fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver adiponectin HFpEF admission
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/HFpEF_admission
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver adiponectin stroke ischemic
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/stroke_ischemic
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver adiponectin DKD progression
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/DKD_progression
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT liver adiponectin MACE 3point
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/liver
via mediator: yggdrasil:mediator/adiponectin
to outcome: yggdrasil:outcome/MACE_3point
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT pancreas klotho fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/pancreas
via mediator: yggdrasil:mediator/klotho
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT pancreas FGF23 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/pancreas
via mediator: yggdrasil:mediator/FGF23
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT pancreas SHBG fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/pancreas
via mediator: yggdrasil:mediator/SHBG
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0

tuple/BAT pancreas GDF15 fibrosis F3
type: MASLD 4tuple hypothesis
source a: yggdrasil:organ/BAT
source b: yggdrasil:organ/pancreas
via mediator: yggdrasil:mediator/GDF15
to outcome: yggdrasil:outcome/fibrosis_F3
priority: 0.6779
novelty: 1.0
published: 0